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Infertility is one of the major health concerns in the world whose 
globally incidence rate is on the rise. Several hormones are 
effective in this process, such as testosterone, estrogen and 
Osteocalcin (OCN). The Osteocalcin has Gprc6a receptors on 
leydig cells, which promotes the production of testosterone when 
mounted on these receptors. Therefore, the aim of this study was 
to investigate the role of Osteocalcin on the improvement of 
spermatogenesis and expression of Gprc6a receptors on leydig 
cells in the azoospermic mouse model. 
Twenty-five mice (4 to 6 weeks) were randomly divided into five 
groups: control, sham I Group that was initially injected by 
busulfan solvent (DMSO) at 5 week old and then by Osteocalcin 
solvent (PBS) after 5 weeks for one months, azoospermia Group 
that received busulfan (40 mg/kg/ip) at 5 week old. Sham II Group 
received busulfan 40mg/kg/ip and then after 5 weeks received PBS 
and experimental group, including azoospermic mice, was 
administered by Osteocalcin (3ng/g/d) for one month. After the 
last injection, the testes were dissected and then exposed to the 
tissue passage. To measure morphological changes, H & E staining 
was performed on a number of sections to measure the diameter of 
the seminiferous tubule, thickness of the germinal layer, count the 
spermatogonial cells, spermatocyte, round spermatid, long 
spermatid, Sertoli, leydig and myoid cells. Image J software was 
used to conduct quantitative studies. Immunohistochemical method 
was employed to examine the expression of specific receptor of 
Osteocalcin, Gprc6α, in the Leydig cell among the groups. 
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Introduction 
 
Infertility is one of the major health concerns in the world whose globally 
incidence rate is on the rise (1). Different global statistics equate the roles of 
women and men in the infertility and the male factor is responsible for almost 
half of the infertility(2).  
The main function of the testes is the synthesis of sex hormones and the 
production of spermatozoa (3). It has been revealed that many hormones affect 
the fertility process, most notably testosterone and estrogen(4). Osteocalcin 
(OCN) is another hormone that is known to influence the spermatogenesis. The 
Osteocalcin is released by osteoblasts and effected in male fertility in transgenic 
mouse models by increasing testosterone production and sperm count(5). The 
Osteocalcin directly controls the formation of testosterone by the leydig cells in 
the testes by its receptor (Gprc6α) (6). The function of androgen receptors is 
essential for the sexual differentiation in the male embryo, the development in 
puberty, reproduction and differentiation of the germ cells, the support of germ 
cells and the regulation of the spermatogenesis process in mammals(7). 
Chemotherapy and radiotherapy preferably disrupt the function of dividing 
cells, including spermatogonium and spermatocyte in the testicles. These 
treatments have significant effects on the spermatogenesis. (8). Lee et al. (2011) 
stated that the bone might play a role in controlling male fertility, with an 
emphasis on the direct role of Osteocalcin in testosterone production in leydig 
cells(4). The authors compared OCN knocked out mice or ESP knocked out 
mice with the control group to support this data, in vivo. They observed that 
the testes weight, the sperm count and the circulating testosterone level had 
been decreased dramatically in the OCN knocked out mice and were increased 
in the ESP knocked out male mice. In addition, they reported that the deletion 
of Gprc6a led to the emergence of a testicular phenotype with a decrease in the 
The H & E staining showed a significant difference in the count the 
spermatogonial cells, spermatocytes, round spermatids, long 
spermatids, thickness of the germ layer, the seminiferous tubule 
diameter between the studied groups (P<0.05). 
There was also no significant difference in the count of Sertoli, 
leydig, myoid cells and seminiferous tubule diameter between the 
groups (P<0.05). In the immune histochemistry, no significant 
difference was found in the count of GpRC6α-positive leydig cells 
between the groups (P< 0.05). 
According to the current results, the OCN plays an important role 
in spermatogenesis, which has a positive effect on the count of 
spermatocytes and spermatids, and can be further explored as an 
appropriate therapeutic strategy proposed for the infertility. 
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testosterone level. Therefore, they stated that the Gprc6a dysexpression, 
induced mice with phenotype similar to the OCN knocked out mice(4). Oury et 
al. (2012) studied the interrelationship between bones and gonads, and stated 
that the skeletal system is an endocrine gland that promotes the synthesis of 
testosterone by the secretion of Osteocalcin hormone. The testosterone and the 
estrogen are important for maintaining the integrity of the skeleton bone mass 
in male and female during puberty(9).  
In this study we examined the effect of Osteocalcin on the promotion of 
spermatogenesis in the azoospermic mouse model, also we investigated 
expression of Gprc6a receptors on leydig cells as OCN receptor. 
 
 
 
Materials and Methods 
 
Animal Preparation 
 
Male mice (NMRI) ranging in age from 4 to 6 weeks (22±5 g) were obtained 
from the Pasteur institute of Iran. Animals were housed in wire cages at 
22±1˚C under a 12 h light dark cycle with 70% humidity and fed a standard 
diet and water. Animals were maintained and experiments were conducted in 
accordance with the Principles of Laboratory Animal Care of Tehran University 
of Medical Sciences, Iran. The Animal Ethical Committees of the Tehran 
University of Medical Sciences approved the use of animals for the study.  
All animals were randomly allocated into five groups, Control group (n=5), 
Azoospermic experimental group (n=5) that received a single intraperitoneal 
injection of busulfan (40 mg/kg body weight) diluted in DMSO(dimethyl 
sulfoxide, USA) at 5 week old (10), Sham I group(n=5) that received a single 
intraperitoneal injection of DMSO (busulfan solvent) at 5 week old , Sham II 
group(n=5) that received a single intraperitoneal injection of DMSO at 5 week 
old and after 5 weeks they received PBS(phosphate buffer solution) 
intraperitoneal injection 0.3ml/d for 1 month and Azoospermic experimental 
treated  group (n=5) that received a single intraperitoneal injection of busulfan 
(40 mg/kg body weight) diluted in DMSO at 5 week old and after 5 weeks they 
received Recombinant Osteocalcin (OCN)(H00000632, novus,USA) 
intraperitoneal injection 3ng/gr/d for 1 month(11).  
 
Drugs preparation 
 
Busulfan (B2635, Sigma, USA) was first dissolved in DMSO (P8340, 
Sigma, USA), then an equal volume of sterile water was added to obtain a final 
busulfan concentration of 20 mg/ml. Osteocalcin dissolved in PBS (P4417, 
Sigma, USA) and then ten-week-old mice that previosely injected with busulfan 
(40 mg/kg body weight) on 5 week old were treated by i.p. injections with 
recombinant Osteocalcin (3 ng/g daily) for 1 month(12). 
Surgical procedure 
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At the end of the treatment period, (15th week) the mice were weighed and 
anesthetized by using intraperitoneal ketamine (50mg/kg and xylezin 20mg/kg), 
blood depletion done from heart and then mice killed; the peritoneal cavity was 
opened through a lower transverse abdominal incision. Left testes in all groups 
were immediately removed, weighed and put in fixative for staining (13).  
 
 
Preparation of Busulfan-Induced Azoospermic Model 
 
The busulfan-treated infertile mouse model was prepared as described by 
Brinster with some modification.  Mice were received a single dose 
intraperitoneal injection of busulfan (40 mg/kg, Sigma, St. Louis, MI, USA) at 
4-6 weeks of age. Hematoxylin-Eosin stain of testicular cross section also eosin 
Nigrosine staining of seminal fluid was performed to evaluate the Azospermic 
model 5 weeks after busulfan injection (10, 14)  
 
 
Confirmation of Busulfan-Induced Azoosperic Model 
 
Hematoxylin and eosin (H&E) staining technique 
 
Hematoxylin and eosin (H&E) stains have been used for at least a century 
and are still essential for recognizing various tissue types and the morphologic 
changes. Testes tissues of control and azoospemic mouse were fixed in buine’s 
solution, embedded in paraffin, sectioned at 5μm and sections were stained with 
hematoxylin and eosin (H&E), then morphological aspect of  seminiferous 
tubules studied (15). 
 
 
The eosin‐nigrosin staining technique 
 
Eosin-Nigrosin is a staining technique that assesses the vitality of a sperm 
sample. Briefly 20 μl of semen were gently stirred (30 s at 37 °C) in 60 μl of 
eosin‐nigrosin stain (5%-nigrosin and 4%-eosin-Y at ratio 3:1). Then, smears 
were prepared and dried at room temperature. The slides were examined by a 
single observer with phase-contrast microscope (magnification: X 1000) after 
preparation. A total of 200 spermatozoa per slide were scored for dead/live 
spermatozoa. This method is based on the degree of membrane permeability of 
dead spermatozoa which heads show pink or red coloration, whereas the low 
permeability of live gametes excludes eosin and therefore their head maintains 
whitish. Sperm that were stained, classified as dead, with sole exclusion for 
sperm with a light pink appearance to the neck region, which were described as 
live (14). 
 
 
 
Immunohistochemistry for Gprc6α 
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Testes tissues were fixed in Formaldehyde solution, embedded in paraffin, 
sectioned at 5μm, after antigen retrieval, endogenous peroxidase blocking, 
sections were incubated with primary polyclonal anti Gprc6α (sc-67302, Santa 
Cruz, 1/100/overnight) and then secondary HRP conjugated antibody 
(ab6721,abcam,1/100/2h) was added. Counterstain nucleus staining was done 
by hematoxilin.  
 
Statistics 
 
     The results were expressed as mean ± SE. The statistical significance 
between the mean values was determined by one-way ANOVA analysis of 
variance, Tukey and Duncan post-test. P≤0.05 was considered significant. 
 
 
Results 
 
Osteocalcin increased testes weight of azoospermic mice 
 
Testis weight was reduced in azoospermic and sham II group compared to 
control and sham I groups, but in azoospermic OCN treated group is more than 
azoospermic mice (Fig. 1) (p≤0.05).  
 
 
Figure 1- Testis weight in different groups. Testis weight was reduced in 
azoospermic and Sham II groups compared to control and Sham I group, but in 
azoospermic OCN treated group is more than azoospermicand Sham II mice 
(p≤0.05).   #   significant with control group; * significant with Sham1 group; • 
significant with azoospermic group; °  significant with Sham II group. 
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Confirmation of the azoospermic model 
  
The results of the eosin-nigrosin staining technique for confirmation of the 
azoospermic model, which was investigated by the phase-contrast microscope, 
indicated penetration of acidic dye into the dead sperm head that is therefore 
visible in pink, while the live sperm head is colorless (Fig. 2 A, B). In addition, 
the results of Hematoxylin-Eosin staining for counting the seminiferous tubule 
examined by optical microscopy indicated that the tubules were relatively 
emptied and vacuolated in the azoospermia group in comparison to the control 
group, and the absence of the germ layer cells shows the destruction of 
spermatogenesis (Fig. 2 C, D). 
 
 
 
Figure 2: The Eosin-Nigrosin-stain produces a dark background on which the 
sperm stand out as lightly colored objects. (A) Dead sperm take up eosin and 
appear pinkish in color (B) whereas normal live sperm exclude the eosin stain 
and appear white in color. Busulfan induced azoospermic model preparation. C: 
Histological morphology of untreated testicle, as normal control; D: Histological 
morphology of testicular tissue 5 week after injection with 40 mg/kg busulfan. 
Most of the endogenous sperm cells had been removed, while interstitial tissue 
and Sertoli cells remained (bar: 50). 
 
 
Evaluation of the variables of the seminiferous tubule 
 
The results of hematoxylin-eosin staining for Morpholog analyzing of the 
seminiferous tubule are shown in figure 3. The control and sham I groups 
contain normal spermatogenesis and thick germ layer of the testicular tissue, 
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but testicular tissue in the azoospermia and sham II groups, the tubules were 
relatively vacuolated. The absence of the germ layer cells shows the destruction 
of spermatogenesis.  The testicular tubules in the Osteocalcin treated group, 
thick germ layer and the presence of various germ cells show the improvement 
and presence of spermatogenesis. 
 
 
 
Figure 3- Hematoxylin-eosin staining: (A) Leydig cell (arrow) display in the 
testicular interstitial tissue; (B) Cross-section of the testicular tissue in the 
control group with normal spermatogenesis and thick germ layer; (C) Cross-
section of testicular tissue in sham I group; (D) Cross-section of testicular tissue 
in the azoospermia group, the tubules were relatively vacuolated. The absence 
of the germ layer cells shows the destruction of spermatogenesis; (E) Cross-
section of the testicular tissue in the sham II group, see the presence of vacuoles 
and absence of the germ layer cells; (F) Cross-section of the testicular tissue in 
the group treated with Osteocalcin, thick germ layer and the presence of various 
germ cells show the improvement and presence of spermatogenesis (bar: 100 in 
A and 50 in B, C, D, E, F). 
 
Based on the one-way ANOVA and according to the Tukey's test there was 
a significant difference between the groups in the number of spermatogonial 
cells, spermatocytes, round spermatid and elongated spermatid and the 
thickness of the germinal layer of the seminiferous tubule (P<0.05). Also there 
was no significant difference in the number of Sertoli, leydig and myoid cells 
and diameter of the seminiferous tubule between the groups (P>0.05) (Fig.4). 
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Figure 4: Data of the Variables of the testis Seminiferous Tubule.  A: number 
of spermatogonia cells; B: Spermatocytes; C: Round spermatid cells; D: 
Elongated spermatid cells; E: Sertoli cells; F: Leydig cells; G: Myoid cells; H: 
Germinal layer thickness; I: Seminiferous tubules diameter (P<0.05). # 
Significant with control group;  * Significant with sham1 group;   •Significant 
with Azoospermic group; ° Significant with sham2 group; Control: Control 
group; Sham I:  which received solvents (DMSO and PBS); azospermia : 
Azoospermiac animals that received busulfan 40 mg/kg/Ip; Sham-II: 
Azoospermiac mice received PBS for 1month; Experimental: azoospermic mice 
that received Osteocalcin. 
 
 
Expression of Gprc6α  
 
The findings of immunohistochemical staining for the evaluation of GpRC6α-
positive cells are presented in figure 5. The findings from the expression of the 
Osteocalcin receptor, GPRC6α, based on one-way ANOVA and Tukey's test 
indicated no significant difference in the count of GpRC6α-positive cells 
between the groups (Fig. 5) (P≤ 0.05). 
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Figure 5- Immunohistochemical staining: (A) GpRC6α-positive leydig cell 
(arrow head) display in the testicular interstitial tissue; (B) Cross-section of the 
testicular tissue in the control group with normal spermatogenesis and thick 
germinal layer; (C) Cross-section of testicular tissue in sham I group; (D) Cross-
section of testicular tissue in the azoospermia group, the tubules were relatively 
vacuolated and germinal layer cells were absent that shown the destruction of 
spermatogenesis; (E) Cross-section of the testicular tissue in the sham II group, 
the presence of vacuoles and  tubules without any germinal cells; (F) Cross-
section of the testicular tissue in the group treated with Osteocalcin, thick 
germinal layer and the presence of various germ cells show the improvement 
and presence of spermatogenesis (bar: 40 in A and 25 in B, C, D, E, F). 
Control: Control group; Sham I:  which received solvents (DMSO and PBS); 
azospermia : Azoospermiac animals that received busulfan 40 mg/kg/Ip; Sham-
II: Azoospermiac mice received PBS for 1month; Experimental: azoospermic 
mice that received Osteocalcin. The number of GpRC6α-positive leydig cells, no 
significant difference was seen between the groups (P≤0.05). 
 
 
 
Discussion 
 
The experimental studies have proven that there are deficiencies in the 
Osteocalcin messaging pathway that are important in the male infertility. 
In the present study, increasing the number of germ cells following the 
injection of Osteocalcin on the azoospermic mouse model confirmed that the 
Osteocalcin could play an important role in the spermatogenesis and fertility. 
Oury et al. were shown that osteocalcin is a bone-derived hormone favoring 
fertility in male mice by promoting Leydig cell maturation and testosterone 
production (6),  Although  in another study they shown that histological 
analysis of testes of 10-week-old male mice injected with osteocalcin failed to 
show any improvement in spermatogenesis or a reversal of their Leydig cell 
(16). Also they confirmed that Osteocalcin–/– male mice are subfertile with a 
marked decrease in circulating testosterone and low sperm count (17).   
Pi et al. for the first time suggested the role of GPRC6A in testicular 
function by creating GPRC6A-/- mice. The GPRC6A is widely expressed in 
many tissues and organs, including the lung, liver, spleen, heart, kidneys, 
skeletal muscle, testicles, brain and bones. Although the metabolic function of 
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several organs is affected by the malfunction of the GPRC6A gene in mice, but 
the most prominent feature is the incidence of woman lines in male GPRC6A-/- 
mice, which is associated with decreased testosterone levels and increased 
estrogen levels (18-20). These male mice were infertile that showed a decrease in 
the testosterone levels and the sperm count (17).  In addition, the study of 
polymorphism in rs2274911 in the GPRC6A gene has been shown in several 
groups of patients as this polymorphism is associated with cryptorchidism in 
children and different phenotypes in adults (21). Oury et al. examined the 
patients with testicular dysfunction and observed that two of them were 
heterozygous for the mutation in the exon 4 of the GPRC6A gene, meaning 
that this mutation affects a highly conserved amino acid located in one of cross 
membrane regions of the molecule. This mutation prevents the integration of 
this protein in the cell membrane and thus causes the GPRC6A dysfunction. 
Cell-based evaluations have shown that this mutation also affects the negative 
dominant status in the cells. In fact, these observations indicate that the 
Osteocalcin deficiency and its receptor, GPRC6A, could play an important role 
in the phenotypic incidence of testicular dysfunction (16). 
Recent studies confirmed that the pancreas-bone-testis axis has direct, 
bilateral and functional effects on each other as well as evolution through its 
discharge. In addition, the hypothalamic-pituitary-testicular axis operates 
predominantly against this axis, increases the exogenous levels of Osteocalcin, 
consequently enhances the level of testosterone and spermatogenesis, and then 
remains somewhat stable (16, 22). 
Kirmani et al. found a direct relationship between total OCN and 
testosterone in boys aged between 11 and 14 years(23). On the other hand, 
Kanazawa et al. observed a strong association between ucOCN and serum 
testosterone levels in the males with type II diabetes (24). The results of 
Legrand et al. (2001) were contradictory to these observations. They evaluated 
40 men and 80 women with osteoporosis and found no association between OCN 
and testosterone serum level (25). Another study on 614 men aged 65-88 years 
showed that the serum Osteocalcin had a negative correlation with free 
testosterone levels (26). 
The difference between the results of the studies is probably due to the 
difference in the population studied in terms of age, model and other factors. 
On the other hand, the results of the present study regarding the 
relationship between OCN, and testis weight represent a strong relationship, 
inconsistent with the results of the Schwetz et al study. They found no strong 
association between OCN, testosterone levels, sperm concentration and 
spermatogenesis (5, 27). However Oury was observed that osteocalcin in  
transgenic mice increased testes, epididymides, and seminal vesicle weights, 
sperm count, and circulating testosterone levels (16). Osteocalcin has emerged 
as an important regulator of glucose and lipid metabolism, β cell proliferation, 
glucose tolerance and insulin sensitivity. These mechanism and function of 
osteocalcin revealed that it indirectly could regulate spermatogenesis and 
fertility (12). 
The mechanism of the effect of Osteocalcin on testosterone is still unknown 
in human beings, but is relatively clear in animal models. The Osteocalcin plays 
a role through the pancreas-bone-testis axis in line and independent of the 
hypothalamic-pituitary-testicular axis, promotes testosterone biosynthesis, and 
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thus regulates reproductive performance and sperm production in men (28, 29), 
however our data confirmed the hypothalamic-pituitary-testicular axis is 
dominant in spermatogenesis and fertility. 
 
 
Conclusion 
 
According to the present results, the presence of OCN plays a major role in 
the functioning of the reproductive system and improves spermatogenesis in the 
azoospermic model, has a positive effect on the number of germ cells and 
expression of GPRC6a and can be further explored as an appropriate 
therapeutic strategy proposed for infertility. 
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